» Articles » PMID: 15660865

Changes in Seroprevalence of Hepatitis A in Children and Adolescents in Manisa, Turkey

Overview
Journal Pediatr Int
Specialty Pediatrics
Date 2005 Jan 22
PMID 15660865
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis A virus (HAV), being an enteric transmitting virus wide world, occurs mostly in children of developing countries. However, the virus has recently been seen in adolescents and young adults worldwide. The aim of the present study was to evaluate the seroprevalence of the HAV infection in children and adolescents in Manisa, Turkey, and to verify whether the increased incidence of HAV infection in other parts of the world and Turkey generally is also true for the area of Manisa.

Methods: The authors studied blood samples of 1395 adolescents and children aged between 6 months and 17 years from the Manisa area in order to evaluate the existence of anti-HAV antibodies using micro-ELISA test.

Results: Total seropositivity was 44.6% while age related values were as followed: 6-23 months, 47.8%; 2-6 years, 23.7%; 7-10 years, 43.4%; 11-14 years, 52.4%; and 15-17 years, 76.6%. These results suggest that the seropositivity increases significantly among children at school age and also increases parallel to age.

Conclusions: According to these results, the authors concluded that there has been a shift of seropositivity from children to adolescents especially in families with an average or high socio-economical level.

Citing Articles

Age-Specific Seroprevalence of Hepatitis A Virus in Turkey Between 2000 and 2023: Systematic Review and Meta-Analysis.

Ciftci I, Koroglu M, Demiray T, Terzi H, Kahraman Kilbas E Diagnostics (Basel). 2024; 14(22).

PMID: 39594130 PMC: 11592513. DOI: 10.3390/diagnostics14222464.


Examining the changes in the prevalence of Hepatitis a in Türkiye: systematic review and metaanalysis.

Suzan O, Bektas M, Altindis M, Kaya O, Eroglu A, Cetinkaya Ozdemir S BMC Public Health. 2024; 24(1):3280.

PMID: 39593006 PMC: 11590238. DOI: 10.1186/s12889-024-20783-4.


A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.

Badur S, Ozturk S, Ozakay A, Khalaf M, Saha D, Van Damme P Hum Vaccin Immunother. 2021; 17(10):3710-3728.

PMID: 34213403 PMC: 8437515. DOI: 10.1080/21645515.2021.1920871.


Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Lazcano-Ponce E, Conde-Gonzalez C, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y Hum Vaccin Immunother. 2013; 9(2):375-81.

PMID: 23291940 PMC: 3859760. DOI: 10.4161/hv.22774.


Seroprevalence of hepatitis a in patients with chronic hepatitis C in isfahan province.

Shoaei P, Zeidabadinejad L, Hassannejad R, Ataei B, Yaran M, Kassaian N Int J Prev Med. 2012; 3(Suppl 1):S102-6.

PMID: 22826750 PMC: 3399306.